已发表论文

预测甲状腺癌发生和发展的 EMT 相关基因特征的鉴定

 

Authors Li Q, Jiang S, Feng T, Zhu T, Qian B

Received 8 January 2021

Accepted for publication 29 April 2021

Published 12 May 2021 Volume 2021:14 Pages 3119—3131

DOI https://doi.org/10.2147/OTT.S301127

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Sanjay Singh

Background: The detection rate of thyroid cancer (TC) has been continuously improved due to the development of detection technology. Epithelial–mesenchymal transition (EMT) is thought to be closely related to the malignant progression of tumors. However, the relationship between EMT-related genes (ERGs) characteristics and the diagnosis and prognosis of TC patients has not been studied.
Methods: Four datasets from Gene Expression Omnibus (GEO) were used to perform transcriptomic profile analysis. The overlapping differentially expressed ERGs (DEERGs) were analyzed using the R package “limma”. Then, the hub genes, which had a higher degree, were identified by the protein–protein interaction (PPI) network. Gene expression analysis between the TC and normal data, the disease-free survival (DFS) analysis of TC patients from The Cancer Genome Atlas Thyroid Cancer (TCGA-THCA) cohort, function analysis, and immunohistochemistry (IHC) were performed to verify the importance of the hub genes. Finally, a prognostic risk scoring was constructed to predict DFS in patients with the selected genes.
Results: A total of 43 DEERGs were identified and 10 DEERGs were considered hub ERGs, which had a high degree of connectivity in the PPI network. Then, the differential expressions of FN1, ITGA2 , and KIT  between TC and normal tissues were verified in the TCGA-THCA cohort and their protein expressions were also verified by IHC. DFS analysis indicated upregulations of FN1  expression (< 0.01) and ITGA2  expression (< 0.01) and downregulation of KIT  expression (=0.01) increased risks of decreased DFS for TCGA-THCA patients. Besides, by building a prognostic risk scoring model, we found that the DFS of TCGA-THCA patients was significantly worse in high-risk groups.
Conclusion: In summary, these hub ERGs were potential biomarkers for diagnosis and prognosis of TC, which can provide a basis for further exploring the efficacy of EMT in patients with TC.
Keywords: thyroid cancer, EMT, signature, bioinformatic analysis, immunohistochemistry